Related Experiment Video

Updated: Aug 13, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

[Testing for hepatitis C]

H Hofmann1, C Kunz

  • 1Institut für Virologie, Universität Wien.

Wiener Klinische Wochenschrift
|February 16, 1990
PubMed

Insights

Hepatitis C virus (HCV) causes approximately 12% of all hepatitis cases in Austria. High prevalence was observed in Austrian drug addicts (80%) and polytransfused patients (44.8%).

Area of Science:

  • Virology
  • Infectious Diseases
  • Hepatology

Context:

  • Hepatitis diagnosis at Vienna University over 10 years revealed diverse etiological agents.
  • Non-A, non-B hepatitis (NANB) constituted 25.8% of diagnosed cases.
  • Hepatitis C virus (HCV) was investigated as a primary cause of NANB.

Purpose:

  • To determine the prevalence of hepatitis C virus (HCV) in Austria.
  • To identify risk groups associated with HCV infection.
  • To analyze the etiological spectrum of hepatitis cases.

Summary:

  • Hepatitis C virus (HCV) was detected in 9.6% of acute and 44.9% of chronic non-A, non-B hepatitis cases.
  • An estimated 12% of all hepatitis cases in Austria are attributed to HCV.
  • High HCV prevalence was noted in drug addicts (80%), polytransfused patients (44.8%), and within a specific dialysis unit (30%).

Impact:

  • This study highlights the significant burden of hepatitis C in Austria.
  • Identifies key populations at high risk for HCV infection, informing targeted public health interventions.
  • Provides crucial epidemiological data for hepatitis C prevention and control strategies in the region.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...